Skip to product information
1 of 1

Mesa BioTech Inc RT-PCR Control Kit Accula™ SARS-CoV-2 Low Positive / High Positive / Negative Level 3 X 3 Swabs - KT/1 - COV41001-KT

Mesa BioTech Inc RT-PCR Control Kit Accula™ SARS-CoV-2 Low Positive / High Positive / Negative Level 3 X 3 Swabs - KT/1 - COV41001-KT

Regular price $129.99
Sale price $129.99 Regular price
OFF Sold out
Shipping calculated at checkout.

50 In stock

Estimated deliver:

Flat-Rate Shipping from $8.25

  • American Express
  • Diners Club
  • Discover
  • Mastercard
  • Shop Pay
  • Visa
View full details
Reviews

Mesa BioTech Inc RT-PCR Control Kit Accula™ SARS-CoV-2 Low Positive / High Positive / Negative Le...

Item Id 1207813
MF Id# COV41001
Brand Accula™
Manufacturer Mesa BioTech Inc
Country of Origin Unknown
Application Control Kit
For Use With For use with Accula SARS-CoV-2 Test and the Accula Dock or Silaris Dock
Form Swab
Levels Low Positive / High Positive / Negative Level
Test Name SARS-CoV-2
Test Type RT-PCR
UNSPSC Code 41116128
Volume 3 X 3 Swabs

Features

  • Emergency Use Authorization (EUA) only: https://www.fda.gov/medical-devices/emergency-situations-medical-devices/emergency-use-authorizations
  • Product ships with minimum 30 days dating
  • Testing is authorized for laboratories certified under the Clinical Laboratory Improvement Amendments of 1988 (CLIA), 42 U.S.C. §263a, to perform high and moderate complexity tests
  • The Accula SARS-CoV-2 Test using nasal swab specimens is also authorized to be distributed and used in patient care settings outside of the clinical laboratory environment
  • Accula SARS-CoV-2 Test results are for the identification of SARS-CoV-2 RNA; the SARS-CoV-2 RNA is generally detectable in nasal swab specimens during the acute phase of infection
  • Positive results are indicative of the presence of SARS-CoV-2 RNA; clinical correlation with patient history and other diagnostic information is necessary to determine patient infection status
  • Positive results do not rule out bacterial infection or co-infection with other viruses
  • Testing facilities within the United States and its territories are required to report all positive results to the appropriate public health authorities
  • Negative results do not preclude SARS-CoV-2 infection and should not be used as the sole basis for patient management decisions; negative results must be combined with clinical observations, patient history, and epidemiological information
  • The Accula SARS-CoV-2 Test is intended for use by trained operators who are proficient in performing tests on the Accula Dock and Silaris Dock; the Accula SARS-CoV-2 Test is only for use under the Food and Drug Administration’s Emergency Use Authorization
  • 9 Control swabs: 3 Sets of Controls (High Positive, Low Positive, Negative)
About your query!
Recently Viewed